AASS

UniProt ID: Q9UDR5
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

AASS (alpha-aminoadipic semialdehyde synthase; alias LKR/SDH) is a mitochondrial bifunctional enzyme that catalyzes the first two committed steps of the main (saccharopine) pathway of L-lysine degradation in the mitochondrial matrix. Its N-terminal domain carries lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) activity, which condenses L-lysine with 2-oxoglutarate to form L-saccharopine using NADPH; its C-terminal domain carries saccharopine dehydrogenase (SDH, EC 1.5.1.9) activity, which oxidizes L-saccharopine to L-2-aminoadipate-6-semialdehyde (alpha-aminoadipic semialdehyde) and L-glutamate, reducing NAD+. The two domains are homologous to the yeast Lys1 and Lys9 enzymes, and the protein forms a homotetramer. AASS is expressed broadly with highest levels in liver and is induced by starvation. Loss of AASS activity causes autosomal recessive hyperlysinemia type 1 and saccharopinuria, metabolic conditions that are generally benign; AASS is also secondarily impaired in mitochondrial NADP(H) deficiency (DECRD, due to NADK2 mutation).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005737 cytoplasm
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: Phylogenetic (IBA) placement in cytoplasm. AASS is a mitochondrial-matrix protein; "cytoplasm" is a correct but very broad ancestor localization that is superseded by the specific mitochondrial matrix annotation.
Reason: The precise, well-supported localization is the mitochondrial matrix (Reactome TAS, Ensembl IEA from mouse, UniProt SUBCELL; experimentally confirmed as mitochondrial by PMID:463877). The generic IBA "cytoplasm" call is uninformative relative to the matrix annotation and should not be treated as a core localization.
Propagation Review
Root cause: NO FAILURE NON CORE
Failure modes: GRANULARITY MISMATCH
Supporting Evidence:
PMID:463877
In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
GO:0019477 L-lysine catabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: AASS catalyzes the first two steps of the saccharopine pathway of lysine degradation, the major route of L-lysine catabolism in humans. This is a core biological process for the gene and is independently supported by IMP evidence (PMID:10775527).
Reason: The phylogenetic assignment matches the experimentally established function: AASS converts L-lysine to alpha-aminoadipic semialdehyde, the committed entry into lysine catabolism.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
GO:0004753 saccharopine dehydrogenase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Grouping (parent) term for saccharopine dehydrogenase activity, assigned by phylogenetic inference. AASS possesses the specific NAD+, L-glutamate-forming SDH activity (GO:0047131); this broader term is a valid but less specific representation.
Reason: Correct at the family level. The C-terminal domain of AASS is the saccharopine dehydrogenase moiety, homologous to yeast Lys9. Retained as a valid grouping; the specific glutamate-forming activity (GO:0047131) captures the core function.
Supporting Evidence:
PMID:10775527
an apparently bifunctional protein, with the N-terminal half similar to that of yeast LYS1 and with the C-terminal half similar to that of yeast LYS9.
GO:0005739 mitochondrion
IEA
GO_REF:0000044
ACCEPT
Summary: Electronic assignment to mitochondrion from UniProt Subcellular Location keyword mapping. Consistent with the experimentally verified mitochondrial localization and the N-terminal mitochondrial transit peptide.
Reason: AASS carries a mitochondrial transit peptide (residues 1-27) and is experimentally localized to mitochondria (PMID:463877); mitochondrion is correct, though the matrix annotation is more specific.
Supporting Evidence:
PMID:463877
saccharopine oxidoreductase was partially purified from human liver and characterized.
GO:0047130 saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic assignment (ARBA/RHEA/EC mapping) of the lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) activity, the first catalytic step of AASS. This is a core molecular function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
Reason: Correct. This term (RHEA:19373, EC 1.5.1.8) is the NADPH-dependent condensation of L-lysine and 2-oxoglutarate to saccharopine catalyzed by the N-terminal LKR domain.
Supporting Evidence:
PMID:10775527
The first two steps in the mammalian lysine-degradation pathway are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
file:human/AASS/AASS-uniprot.txt
Bifunctional enzyme that catalyzes the first two steps in
GO:0047131 saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic assignment (ARBA/RHEA/EC mapping) of the saccharopine dehydrogenase (SDH, EC 1.5.1.9) activity, the second catalytic step of AASS. This is a core molecular function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
Reason: Correct. This term (RHEA:24520, EC 1.5.1.9) is the NAD+-dependent oxidation of saccharopine to alpha-aminoadipic semialdehyde and L-glutamate catalyzed by the C-terminal SDH domain.
Supporting Evidence:
PMID:10775527
The first two steps in the mammalian lysine-degradation pathway are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
GO:0005759 mitochondrial matrix
IEA
GO_REF:0000107
ACCEPT
Summary: Automatic transfer (Ensembl Compara) from the mouse ortholog (Q99K67) placing AASS in the mitochondrial matrix, the compartment where the saccharopine pathway operates.
Reason: Mitochondrial matrix is the correct, specific compartment for this soluble matrix enzyme, consistent with the transit peptide and experimental mitochondrial localization (PMID:463877). This is the core localization.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-70938
ACCEPT
Summary: Reactome (TAS) localization of the LKR reaction (lysine + alpha-ketoglutarate + NADPH => saccharopine) to the mitochondrial matrix. Consistent with the core localization.
Reason: The LKR step of AASS occurs in the mitochondrial matrix; Reactome curates this reaction there. Correct.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-70940
ACCEPT
Summary: Reactome (TAS) localization of the SDH reaction (saccharopine + NAD+ => alpha-aminoadipic semialdehyde + glutamate) to the mitochondrial matrix. Consistent with the core localization.
Reason: The SDH step of AASS occurs in the mitochondrial matrix; Reactome curates this reaction there. Correct.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.
GO:0005739 mitochondrion
EXP
PMID:463877
Familial hyperlysinemia: enzyme studies, diagnostic methods,...
ACCEPT
Summary: Experimental localization of AASS activities to mitochondria, from enzyme studies of the lysine-degrading activities partially purified from human liver.
Reason: Directly supported experimental annotation of mitochondrial localization; consistent with all other localization evidence.
Supporting Evidence:
PMID:463877
saccharopine oxidoreductase was partially purified from human liver and characterized.
GO:0047130 saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
EXP
PMID:463877
Familial hyperlysinemia: enzyme studies, diagnostic methods,...
ACCEPT
Summary: Experimental demonstration of lysine-ketoglutarate reductase (LKR) activity in human cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia. Core molecular function.
Reason: LKR activity was directly assayed and shown deficient in hyperlysinemia patients, establishing this NADP+/L-lysine-forming (EC 1.5.1.8) activity for the human enzyme.
Supporting Evidence:
PMID:463877
In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
GO:0047131 saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
EXP
PMID:463877
Familial hyperlysinemia: enzyme studies, diagnostic methods,...
ACCEPT
Summary: Experimental demonstration of saccharopine dehydrogenase (SDH) activity in human cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia. Core molecular function.
Reason: SDH activity was directly assayed and shown deficient in hyperlysinemia patients, establishing this NAD+/L-glutamate-forming (EC 1.5.1.9) activity for the human enzyme.
Supporting Evidence:
PMID:463877
In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: High-throughput identification of AASS in the high-confidence human mitochondrial proteome (MitoCoP). Corroborates the mitochondrial localization.
Reason: Consistent proteome-scale evidence supporting mitochondrial localization, in agreement with the experimental and computational annotations.
Supporting Evidence:
PMID:34800366
mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
GO:0047130 saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
IMP
PMID:10775527
Identification of the alpha-aminoadipic semialdehyde synthas...
ACCEPT
Summary: Loss-of-function evidence: a homozygous frameshift/premature-stop AASS variant in a hyperlysinemia patient abolishes the enzyme, supporting the LKR (EC 1.5.1.8) activity of AASS. Core molecular function.
Reason: Mutational (IMP) evidence links AASS specifically to the LKR activity of the lysine-degradation pathway.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
GO:0019477 L-lysine catabolic process
IMP
PMID:10775527
Identification of the alpha-aminoadipic semialdehyde synthas...
ACCEPT
Summary: Mutational evidence that AASS is required for L-lysine catabolism: inactivating AASS variants cause hyperlysinemia (accumulation of lysine). Core biological process.
Reason: Directly establishes AASS involvement in the L-lysine catabolic process via a loss-of-function patient allele.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
GO:0047131 saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
IMP
PMID:10775527
Identification of the alpha-aminoadipic semialdehyde synthas...
ACCEPT
Summary: Loss-of-function evidence: an inactivating AASS variant in a hyperlysinemia patient supports the SDH (EC 1.5.1.9) activity of AASS. Core molecular function.
Reason: Mutational (IMP) evidence links AASS to the saccharopine dehydrogenase activity of the lysine-degradation pathway; both AASS activities are lost in the patient.
Supporting Evidence:
PMID:10775527
we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.
GO:0000122 negative regulation of transcription by RNA polymerase II
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: ISS transfer from the Drosophila ortholog dLKR/SDH (UniProtKB:Q9VLX0), which was reported to have a nuclear/transcriptional moonlighting role in fly. No experimental support in human, and the assignment conflicts with the established mitochondrial-matrix metabolic localization of the human enzyme.
Reason: This is a species-specific moonlighting function reported for the Drosophila protein, transferred by sequence similarity from a single non-mammalian ortholog. Human AASS is a mitochondrial-matrix enzyme with no evidence for transcriptional regulation; the transferred nuclear role is not validated for human and is not a core function. Per curation policy this ISS transfer is marked as over-annotated rather than removed.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q9VLX0 · Drosophila melanogaster LKR/SDH (dLKR/SDH) SUPPORTS SOURCE BUT NOT TARGET
Nuclear/transcriptional moonlighting reported for the fly enzyme; not conserved or validated for human AASS.
GO:0003714 transcription corepressor activity
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: ISS transfer from the Drosophila ortholog (UniProtKB:Q9VLX0) of a transcription corepressor moonlighting activity. Not supported for human AASS and inconsistent with its mitochondrial-matrix localization; also a "binding/regulatory" MF that is not the gene's core catalytic function.
Reason: The corepressor role was described for the fly enzyme and transferred by similarity; there is no human experimental evidence, and a mitochondrial-matrix oxidoreductase is not expected to act as a nuclear transcription corepressor. Marked over-annotated.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q9VLX0 · Drosophila melanogaster LKR/SDH (dLKR/SDH) SUPPORTS SOURCE BUT NOT TARGET
Corepressor moonlighting activity reported for the fly enzyme; not validated for human AASS.
GO:0004754 saccharopine dehydrogenase (NAD+, L-lysine-forming) activity
ISS
GO_REF:0000024
MODIFY
Summary: ISS transfer (from Drosophila Q9VLX0) of the L-lysine-forming (biosynthetic, yeast Lys1-type) direction of saccharopine dehydrogenase. This is the reverse (anabolic) reaction; the human enzyme runs the catabolic activities (LKR GO:0047130 and glutamate-forming SDH GO:0047131), not lysine biosynthesis.
Reason: Mammals do not synthesize lysine via saccharopine; AASS is catabolic. The correct catalytic activities are the NADP+, L-lysine-forming reductase (GO:0047130) and the NAD+, L-glutamate-forming dehydrogenase (GO:0047131). The lysine-forming SDH direction (GO:0004754) is the wrong physiological direction for the human enzyme.
Supporting Evidence:
file:human/AASS/AASS-uniprot.txt
the lysine ketoglutarate reductase and saccharopine dehydrogenase
GO:0005829 cytosol
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: ISS transfer of cytosolic localization from the Drosophila ortholog (UniProtKB:Q9VLX0), likely associated with the reported fly moonlighting role. Contradicts the mitochondrial-matrix localization of human AASS.
Reason: Human AASS has an N-terminal mitochondrial transit peptide and is experimentally localized to the mitochondrial matrix; a cytosolic localization transferred from a fly ortholog is not supported and conflicts with the core compartment. Marked over-annotated.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: COMPARTMENT OR COMPLEX MISMATCH
Sources checked:
UniProtKB:Q9VLX0 · Drosophila melanogaster LKR/SDH (dLKR/SDH) SUPPORTS SOURCE BUT NOT TARGET
Human AASS has a mitochondrial transit peptide and matrix localization; cytosolic transfer is unsafe.
GO:0005634 nucleus
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: ISS transfer of nuclear localization from the Drosophila ortholog (UniProtKB:Q9VLX0), linked to the fly transcriptional moonlighting role. No human evidence; conflicts with the established mitochondrial-matrix localization.
Reason: Nuclear localization is part of the Drosophila-specific moonlighting function and is not validated for the human mitochondrial-matrix enzyme. Marked over-annotated.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: COMPARTMENT OR COMPLEX MISMATCH
Sources checked:
UniProtKB:Q9VLX0 · Drosophila melanogaster LKR/SDH (dLKR/SDH) SUPPORTS SOURCE BUT NOT TARGET
Nuclear localization is part of the fly moonlighting role; not validated for the human mitochondrial-matrix enzyme.
GO:0042393 histone binding
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: ISS transfer of histone binding from the Drosophila ortholog (UniProtKB:Q9VLX0), associated with the reported fly chromatin/transcription moonlighting role. Not supported for human AASS.
Reason: Histone binding was inferred from the fly moonlighting function and transferred by similarity; there is no human experimental support, and it is inconsistent with the mitochondrial-matrix metabolic role. Marked over-annotated.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: FUNCTIONAL DIVERGENCE
Sources checked:
UniProtKB:Q9VLX0 · Drosophila melanogaster LKR/SDH (dLKR/SDH) SUPPORTS SOURCE BUT NOT TARGET
Histone binding tied to the fly chromatin moonlighting role; not validated for human AASS.
GO:0005739 mitochondrion
TAS
PMID:10567240
Lysine degradation through the saccharopine pathway in mamma...
ACCEPT
Summary: Author statement (TAS) that the bifunctional LKR/SDH enzyme is a mitochondrial protein, based on sequence analysis of the mammalian (mouse) enzyme. Consistent with the human mitochondrial localization.
Reason: Corroborates mitochondrial localization; the paper characterizes the mammalian bifunctional LKR/SDH and infers a mitochondrial targeting sequence.
Supporting Evidence:
PMID:10567240
the bifunctional enzyme is likely to be a mitochondrial protein.

Core Functions

Lysine-ketoglutarate reductase (LKR) activity: the N-terminal domain condenses L-lysine with 2-oxoglutarate to form L-saccharopine, using NADPH, as the first committed step of the saccharopine pathway of L-lysine degradation in the mitochondrial matrix.

Supporting Evidence:
  • PMID:463877
    In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
  • PMID:10775527
    The first two steps in the mammalian lysine-degradation pathway are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.

Saccharopine dehydrogenase (SDH) activity: the C-terminal domain oxidizes L-saccharopine to L-2-aminoadipate-6-semialdehyde (alpha-aminoadipic semialdehyde) and L-glutamate, reducing NAD+, as the second step of the saccharopine pathway of L-lysine degradation in the mitochondrial matrix.

Supporting Evidence:
  • PMID:463877
    In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
  • PMID:10775527
    The first two steps in the mammalian lysine-degradation pathway are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.

References

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Lysine degradation through the saccharopine pathway in mammals: involvement of both bifunctional and monofunctional lysine-degrading enzymes in mouse.
  • Characterizes a mammalian (mouse) bifunctional lysine-oxoglutarate reductase/saccharopine dehydrogenase and infers mitochondrial localization; also reports starvation induction.
    "the bifunctional enzyme is likely to be a mitochondrial protein."
Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia.
  • Identifies human AASS as a bifunctional enzyme (N-terminal LKR ~ yeast LYS1, C-terminal SDH ~ yeast LYS9) catalyzing the first two steps of lysine degradation; inactivating mutations cause hyperlysinemia.
    "we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia."
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
  • AASS is a member of the high-confidence human mitochondrial proteome (MitoCoP).
    "mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)"
Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on terminology.
  • Enzyme studies in hyperlysinemia patients show combined deficiency of lysine-ketoglutarate reductase and saccharopine dehydrogenase; the activities co-purify from human liver and localize to the same protein.
    "In all instances there was a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities."
Reactome:R-HSA-70938
lysine + alpha-ketoglutarate +NADPH + H+ => saccharopine + NADP+ + H2O
Reactome:R-HSA-70940
saccharopine + NAD+ + H2O => alpha-aminoadipic semialdehyde + glutamate + NADH + H+

Suggested Questions for Experts

Q: Does human AASS have any validated moonlighting function outside the mitochondrion (e.g. a nuclear/transcriptional role analogous to that reported for the Drosophila ortholog), or is such a role restricted to insects?

Suggested Experiments

Experiment: Test whether endogenous AASS is detectable in the nucleus of human cells and whether it associates with chromatin or represses transcription, to determine if the Drosophila-derived transcriptional moonlighting annotations are conserved in humans.

📚 Additional Documentation

Notes

(AASS-notes.md)

AASS (human) — gene review notes

UniProt: Q9UDR5 (AASS_HUMAN); HGNC:17366; gene ID 10157; chromosome 7q31.3.
926 aa precursor; mitochondrial transit peptide (1..27); mature chain 28..926.

Core biology (bifunctional enzyme)

AASS = alpha-aminoadipic semialdehyde synthase, mitochondrial. It is a bifunctional
enzyme (alias LKR/SDH) that catalyzes the first two steps of the main (saccharopine)
pathway of L-lysine degradation
in the mitochondrial matrix:

  1. Lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) — N-terminal domain
    (region 28..476). Condenses L-lysine + 2-oxoglutarate to L-saccharopine using NADPH.
    UniProt CATALYTIC ACTIVITY: "L-saccharopine + NADP(+) + H2O = L-lysine + 2-oxoglutarate
  2. NADPH + H(+)"; PhysiologicalDirection=right-to-left (i.e. lysine-forming direction
    is left, so physiological flux is lysine + 2-OG → saccharopine). RHEA:19373; EC 1.5.1.8.
    GO term: GO:0047130 saccharopine dehydrogenase (NADP+, L-lysine-forming) activity.

  3. Saccharopine dehydrogenase (SDH, EC 1.5.1.9) — C-terminal domain
    (region 477..926). Oxidizes L-saccharopine to (S)-2-amino-6-oxohexanoate
    (= L-2-aminoadipate-6-semialdehyde / alpha-aminoadipic semialdehyde) + L-glutamate,
    reducing NAD+. UniProt: "L-saccharopine + NAD(+) + H2O = (S)-2-amino-6-oxohexanoate +
    L-glutamate + NADH + H(+)"; PhysiologicalDirection=left-to-right. RHEA:24520; EC 1.5.1.9.
    GO term: GO:0047131 saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity.

Net: L-lysine + 2-OG + NADPH → saccharopine → alpha-aminoadipate-6-semialdehyde +
L-glutamate. This is the committed entry into lysine catabolism (steps 1/6 and 2/6 of
glutaryl-CoA from L-lysine; UniPathway UPA00868 UER00835/UER00836).

Structure: homotetramer (by similarity to mouse Q99K67). NAD-binding residues in SDH
domain resolved by crystallography (PDB 5L76/5L78/5O1N/5O1O/5O1P for SDH domain 455-926;
8DDA/8E8T/8E8U/8E8V for LKR domain). L-saccharopine-binding residues 577-578, 604, 703,
724-726 (by similarity to Q9P4R4).

Tissue: expressed broadly, highest in liver. Induced by starvation (by similarity).

Disease

  • Hyperlysinemia type 1 / HYPLYS1 (MIM 238700): autosomal recessive; both AASS
    enzyme activities defective; increased serum lysine (+/- saccharopine); ~half of probands
    asymptomatic; generally considered a benign metabolic variant. PMID:10775527
  • Saccharopinuria: patients retaining significant LKR but low SDH → saccharopine
    accumulation; few/no clinical manifestations. PMID:463877
  • DECRD (MIM 616034): AASS is one of the NADP(H)-dependent mitochondrial enzymes
    secondarily impaired when NADK2 is mutated (mitochondrial NADP(H) deficiency), producing
    hyperlysinemia alongside 2,4-dienoyl-CoA reductase deficiency. PMID:24847004 (AASS is
    affected but the primary defect is in NADK2.)

Annotation assessment

  • GO:0047130 / GO:0047131 (both MF activities): core. Supported by EXP (PMID:463877,
    enzyme assays in human fibroblasts/liver) and IMP (PMID:10775527, loss-of-function
    patient variant). ACCEPT. GO:0004753 (parent "saccharopine dehydrogenase activity", IBA):
    ACCEPT as a valid broader grouping.
  • GO:0004754 (saccharopine dehydrogenase (NAD+, L-lysine-forming) activity, ISS from
    Drosophila Q9VLX0): this is the biosynthetic direction SDH (yeast Lys1-type, lysine
    biosynthesis), NOT the human catabolic activity. Human AASS runs the catabolic SDH
    (GO:0047131, glutamate-forming) and the LKR/NADP+ reductase (GO:0047130). The
    L-lysine-forming SDH is the reverse (anabolic) reaction found in fungi. MARK_AS_OVER_ANNOTATED
    / MODIFY toward GO:0047131. (Kept conservative — ISS transfer picked the wrong catalytic
    direction for a catabolic mammalian enzyme.)
  • GO:0019477 L-lysine catabolic process (IBA + IMP PMID:10775527): core BP. ACCEPT.
  • Localization: mitochondrial matrix (GO:0005759) is the correct, well-supported
    compartment (Reactome TAS, Ensembl IEA from mouse, UniProt SUBCELL). GO:0005739
    mitochondrion (EXP PMID:463877, HTP PMID:34800366, TAS PMID:10567240, IEA) ACCEPT.
  • GO:0005737 cytoplasm (IBA): broad but not wrong (matrix is within cytoplasm-ish
    parent); the phylogenetic call is conservative. Keep but non-core given the precise
    matrix annotation exists.
  • Drosophila-derived moonlighting ISS annotations (all ISS, GO_REF:0000024, WITH
    UniProtKB:Q9VLX0 = D. melanogaster dLKR/SDH): GO:0000122 negative regulation of
    transcription by RNA Pol II, GO:0003714 transcription corepressor activity, GO:0042393
    histone binding, GO:0005634 nucleus, GO:0005829 cytosol. These transfer a fly-specific
    nuclear/transcriptional moonlighting role to human by sequence similarity. No experimental
    support in human; conflicts with the established mitochondrial-matrix metabolic role.
    MARK_AS_OVER_ANNOTATED (per policy, not REMOVE — ISS is an electronic-style transfer but
    the underlying fly biology is real; it is simply unvalidated/non-core for the human enzyme,
    and cytosol/nucleus contradict the matrix localization).

Verbatim quote sources (for supporting_text)

  • PMID:10775527 abstract: "The first two steps in the mammalian lysine-degradation pathway
    are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase,
    respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde."
    and "we propose that AASS catalyzes the first two steps of the major lysine-degradation
    pathway in human cells and that inactivating mutations in the AASS gene are a cause of
    hyperlysinemia." and "an apparently bifunctional protein, with the N-terminal half similar
    to that of yeast LYS1 and with the C-terminal half similar to that of yeast LYS9."
  • PMID:463877 abstract: "In all instances there was a deficiency in lysine-ketoglutarate
    reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities."
    and "saccharopine oxidoreductase was partially purified from human liver ... The activity
    did not separate from that of lysine-ketoglutarate reductase or saccharopine dehydrogenase."
  • PMID:10567240 abstract: "the bifunctional enzyme is likely to be a mitochondrial protein."
    and "both a bifunctional lysine-oxoglutarate reductase/saccharopine dehydrogenase and a
    monofunctional saccharopine dehydrogenase are likely to be present in this organ."
  • PMID:34800366 abstract: "mitochondrial high-confidence proteome of >1,100 proteins
    (MitoCoP)".
  • file: UniProt CATALYTIC ACTIVITY / FUNCTION / SUBCELLULAR LOCATION / DOMAIN sections.

📄 View Raw YAML

id: Q9UDR5
gene_symbol: AASS
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  AASS (alpha-aminoadipic semialdehyde synthase; alias LKR/SDH) is a mitochondrial
  bifunctional enzyme that catalyzes the first two committed steps of the main
  (saccharopine) pathway of L-lysine degradation in the mitochondrial matrix. Its
  N-terminal domain carries lysine-ketoglutarate reductase (LKR, EC 1.5.1.8) activity,
  which condenses L-lysine with 2-oxoglutarate to form L-saccharopine using NADPH; its
  C-terminal domain carries saccharopine dehydrogenase (SDH, EC 1.5.1.9) activity, which
  oxidizes L-saccharopine to L-2-aminoadipate-6-semialdehyde (alpha-aminoadipic
  semialdehyde) and L-glutamate, reducing NAD+. The two domains are homologous to the
  yeast Lys1 and Lys9 enzymes, and the protein forms a homotetramer. AASS is expressed
  broadly with highest levels in liver and is induced by starvation. Loss of AASS activity
  causes autosomal recessive hyperlysinemia type 1 and saccharopinuria, metabolic
  conditions that are generally benign; AASS is also secondarily impaired in
  mitochondrial NADP(H) deficiency (DECRD, due to NADK2 mutation).
existing_annotations:
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic (IBA) placement in cytoplasm. AASS is a mitochondrial-matrix protein;
      "cytoplasm" is a correct but very broad ancestor localization that is superseded by
      the specific mitochondrial matrix annotation.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The precise, well-supported localization is the mitochondrial matrix (Reactome TAS,
      Ensembl IEA from mouse, UniProt SUBCELL; experimentally confirmed as mitochondrial by
      PMID:463877). The generic IBA "cytoplasm" call is uninformative relative to the matrix
      annotation and should not be treated as a core localization.
    propagation_review:
      root_cause: NO_FAILURE_NON_CORE
      failure_modes:
      - GRANULARITY_MISMATCH
    supported_by:
    - reference_id: PMID:463877
      supporting_text: >-
        In all instances there was a deficiency in lysine-ketoglutarate reductase,
        saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- term:
    id: GO:0019477
    label: L-lysine catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      AASS catalyzes the first two steps of the saccharopine pathway of lysine degradation,
      the major route of L-lysine catabolism in humans. This is a core biological process
      for the gene and is independently supported by IMP evidence (PMID:10775527).
    action: ACCEPT
    reason: >-
      The phylogenetic assignment matches the experimentally established function: AASS
      converts L-lysine to alpha-aminoadipic semialdehyde, the committed entry into lysine
      catabolism.
    supported_by:
    - reference_id: PMID:10775527
      supporting_text: >-
        we propose that AASS catalyzes the first two steps of the major lysine-degradation
        pathway in human cells and that inactivating mutations in the AASS gene are a cause
        of hyperlysinemia.
- term:
    id: GO:0004753
    label: saccharopine dehydrogenase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Grouping (parent) term for saccharopine dehydrogenase activity, assigned by
      phylogenetic inference. AASS possesses the specific NAD+, L-glutamate-forming SDH
      activity (GO:0047131); this broader term is a valid but less specific representation.
    action: ACCEPT
    reason: >-
      Correct at the family level. The C-terminal domain of AASS is the saccharopine
      dehydrogenase moiety, homologous to yeast Lys9. Retained as a valid grouping;
      the specific glutamate-forming activity (GO:0047131) captures the core function.
    supported_by:
    - reference_id: PMID:10775527
      supporting_text: >-
        an apparently bifunctional protein, with the N-terminal half similar to that of
        yeast LYS1 and with the C-terminal half similar to that of yeast LYS9.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic assignment to mitochondrion from UniProt Subcellular Location keyword
      mapping. Consistent with the experimentally verified mitochondrial localization and
      the N-terminal mitochondrial transit peptide.
    action: ACCEPT
    reason: >-
      AASS carries a mitochondrial transit peptide (residues 1-27) and is experimentally
      localized to mitochondria (PMID:463877); mitochondrion is correct, though the matrix
      annotation is more specific.
    supported_by:
    - reference_id: PMID:463877
      supporting_text: >-
        saccharopine oxidoreductase was partially purified from human liver and
        characterized.
- term:
    id: GO:0047130
    label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic assignment (ARBA/RHEA/EC mapping) of the lysine-ketoglutarate reductase
      (LKR, EC 1.5.1.8) activity, the first catalytic step of AASS. This is a core molecular
      function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
    action: ACCEPT
    reason: >-
      Correct. This term (RHEA:19373, EC 1.5.1.8) is the NADPH-dependent condensation of
      L-lysine and 2-oxoglutarate to saccharopine catalyzed by the N-terminal LKR domain.
    supported_by:
    - reference_id: PMID:10775527
      supporting_text: >-
        The first two steps in the mammalian lysine-degradation pathway are catalyzed by
        lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
        resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
    - reference_id: file:human/AASS/AASS-uniprot.txt
      supporting_text: >-
        Bifunctional enzyme that catalyzes the first two steps in
- term:
    id: GO:0047131
    label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic assignment (ARBA/RHEA/EC mapping) of the saccharopine dehydrogenase (SDH,
      EC 1.5.1.9) activity, the second catalytic step of AASS. This is a core molecular
      function, corroborated by EXP (PMID:463877) and IMP (PMID:10775527) annotations.
    action: ACCEPT
    reason: >-
      Correct. This term (RHEA:24520, EC 1.5.1.9) is the NAD+-dependent oxidation of
      saccharopine to alpha-aminoadipic semialdehyde and L-glutamate catalyzed by the
      C-terminal SDH domain.
    supported_by:
    - reference_id: PMID:10775527
      supporting_text: >-
        The first two steps in the mammalian lysine-degradation pathway are catalyzed by
        lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
        resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: is_active_in
  review:
    summary: >-
      Automatic transfer (Ensembl Compara) from the mouse ortholog (Q99K67) placing AASS in
      the mitochondrial matrix, the compartment where the saccharopine pathway operates.
    action: ACCEPT
    reason: >-
      Mitochondrial matrix is the correct, specific compartment for this soluble matrix
      enzyme, consistent with the transit peptide and experimental mitochondrial
      localization (PMID:463877). This is the core localization.
    supported_by:
    - reference_id: PMID:10567240
      supporting_text: >-
        the bifunctional enzyme is likely to be a mitochondrial protein.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70938
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) localization of the LKR reaction (lysine + alpha-ketoglutarate + NADPH
      => saccharopine) to the mitochondrial matrix. Consistent with the core localization.
    action: ACCEPT
    reason: >-
      The LKR step of AASS occurs in the mitochondrial matrix; Reactome curates this
      reaction there. Correct.
    supported_by:
    - reference_id: PMID:10567240
      supporting_text: >-
        the bifunctional enzyme is likely to be a mitochondrial protein.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70940
  qualifier: located_in
  review:
    summary: >-
      Reactome (TAS) localization of the SDH reaction (saccharopine + NAD+ => alpha-aminoadipic
      semialdehyde + glutamate) to the mitochondrial matrix. Consistent with the core
      localization.
    action: ACCEPT
    reason: >-
      The SDH step of AASS occurs in the mitochondrial matrix; Reactome curates this
      reaction there. Correct.
    supported_by:
    - reference_id: PMID:10567240
      supporting_text: >-
        the bifunctional enzyme is likely to be a mitochondrial protein.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: EXP
  original_reference_id: PMID:463877
  qualifier: located_in
  review:
    summary: >-
      Experimental localization of AASS activities to mitochondria, from enzyme studies of
      the lysine-degrading activities partially purified from human liver.
    action: ACCEPT
    reason: >-
      Directly supported experimental annotation of mitochondrial localization; consistent
      with all other localization evidence.
    supported_by:
    - reference_id: PMID:463877
      supporting_text: >-
        saccharopine oxidoreductase was partially purified from human liver and
        characterized.
- term:
    id: GO:0047130
    label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
  evidence_type: EXP
  original_reference_id: PMID:463877
  qualifier: enables
  review:
    summary: >-
      Experimental demonstration of lysine-ketoglutarate reductase (LKR) activity in human
      cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia.
      Core molecular function.
    action: ACCEPT
    reason: >-
      LKR activity was directly assayed and shown deficient in hyperlysinemia patients,
      establishing this NADP+/L-lysine-forming (EC 1.5.1.8) activity for the human enzyme.
    supported_by:
    - reference_id: PMID:463877
      supporting_text: >-
        In all instances there was a deficiency in lysine-ketoglutarate reductase,
        saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- term:
    id: GO:0047131
    label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
  evidence_type: EXP
  original_reference_id: PMID:463877
  qualifier: enables
  review:
    summary: >-
      Experimental demonstration of saccharopine dehydrogenase (SDH) activity in human
      cells/liver; deficiency of this activity is characteristic of familial hyperlysinemia.
      Core molecular function.
    action: ACCEPT
    reason: >-
      SDH activity was directly assayed and shown deficient in hyperlysinemia patients,
      establishing this NAD+/L-glutamate-forming (EC 1.5.1.9) activity for the human enzyme.
    supported_by:
    - reference_id: PMID:463877
      supporting_text: >-
        In all instances there was a deficiency in lysine-ketoglutarate reductase,
        saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  qualifier: located_in
  review:
    summary: >-
      High-throughput identification of AASS in the high-confidence human mitochondrial
      proteome (MitoCoP). Corroborates the mitochondrial localization.
    action: ACCEPT
    reason: >-
      Consistent proteome-scale evidence supporting mitochondrial localization, in agreement
      with the experimental and computational annotations.
    supported_by:
    - reference_id: PMID:34800366
      supporting_text: >-
        mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
- term:
    id: GO:0047130
    label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
  evidence_type: IMP
  original_reference_id: PMID:10775527
  qualifier: enables
  review:
    summary: >-
      Loss-of-function evidence: a homozygous frameshift/premature-stop AASS variant in a
      hyperlysinemia patient abolishes the enzyme, supporting the LKR (EC 1.5.1.8) activity
      of AASS. Core molecular function.
    action: ACCEPT
    reason: >-
      Mutational (IMP) evidence links AASS specifically to the LKR activity of the
      lysine-degradation pathway.
    supported_by:
    - reference_id: PMID:10775527
      supporting_text: >-
        we propose that AASS catalyzes the first two steps of the major lysine-degradation
        pathway in human cells and that inactivating mutations in the AASS gene are a cause
        of hyperlysinemia.
- term:
    id: GO:0019477
    label: L-lysine catabolic process
  evidence_type: IMP
  original_reference_id: PMID:10775527
  qualifier: involved_in
  review:
    summary: >-
      Mutational evidence that AASS is required for L-lysine catabolism: inactivating AASS
      variants cause hyperlysinemia (accumulation of lysine). Core biological process.
    action: ACCEPT
    reason: >-
      Directly establishes AASS involvement in the L-lysine catabolic process via a
      loss-of-function patient allele.
    supported_by:
    - reference_id: PMID:10775527
      supporting_text: >-
        we propose that AASS catalyzes the first two steps of the major lysine-degradation
        pathway in human cells and that inactivating mutations in the AASS gene are a cause
        of hyperlysinemia.
- term:
    id: GO:0047131
    label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
  evidence_type: IMP
  original_reference_id: PMID:10775527
  qualifier: enables
  review:
    summary: >-
      Loss-of-function evidence: an inactivating AASS variant in a hyperlysinemia patient
      supports the SDH (EC 1.5.1.9) activity of AASS. Core molecular function.
    action: ACCEPT
    reason: >-
      Mutational (IMP) evidence links AASS to the saccharopine dehydrogenase activity of the
      lysine-degradation pathway; both AASS activities are lost in the patient.
    supported_by:
    - reference_id: PMID:10775527
      supporting_text: >-
        we propose that AASS catalyzes the first two steps of the major lysine-degradation
        pathway in human cells and that inactivating mutations in the AASS gene are a cause
        of hyperlysinemia.
- term:
    id: GO:0000122
    label: negative regulation of transcription by RNA polymerase II
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: involved_in
  review:
    summary: >-
      ISS transfer from the Drosophila ortholog dLKR/SDH (UniProtKB:Q9VLX0), which was
      reported to have a nuclear/transcriptional moonlighting role in fly. No experimental
      support in human, and the assignment conflicts with the established mitochondrial-matrix
      metabolic localization of the human enzyme.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is a species-specific moonlighting function reported for the Drosophila protein,
      transferred by sequence similarity from a single non-mammalian ortholog. Human AASS
      is a mitochondrial-matrix enzyme with no evidence for transcriptional regulation; the
      transferred nuclear role is not validated for human and is not a core function.
      Per curation policy this ISS transfer is marked as over-annotated rather than removed.
    propagation_review:
      root_cause: PROPAGATION_BAD
      failure_modes:
      - FUNCTIONAL_DIVERGENCE
      source_entities:
      - source_id: UniProtKB:Q9VLX0
        source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Nuclear/transcriptional moonlighting reported for the fly enzyme; not conserved
          or validated for human AASS.
- term:
    id: GO:0003714
    label: transcription corepressor activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      ISS transfer from the Drosophila ortholog (UniProtKB:Q9VLX0) of a transcription
      corepressor moonlighting activity. Not supported for human AASS and inconsistent with
      its mitochondrial-matrix localization; also a "binding/regulatory" MF that is not the
      gene's core catalytic function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The corepressor role was described for the fly enzyme and transferred by similarity;
      there is no human experimental evidence, and a mitochondrial-matrix oxidoreductase is
      not expected to act as a nuclear transcription corepressor. Marked over-annotated.
    propagation_review:
      root_cause: PROPAGATION_BAD
      failure_modes:
      - FUNCTIONAL_DIVERGENCE
      source_entities:
      - source_id: UniProtKB:Q9VLX0
        source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Corepressor moonlighting activity reported for the fly enzyme; not validated for
          human AASS.
- term:
    id: GO:0004754
    label: saccharopine dehydrogenase (NAD+, L-lysine-forming) activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      ISS transfer (from Drosophila Q9VLX0) of the L-lysine-forming (biosynthetic, yeast
      Lys1-type) direction of saccharopine dehydrogenase. This is the reverse (anabolic)
      reaction; the human enzyme runs the catabolic activities (LKR GO:0047130 and
      glutamate-forming SDH GO:0047131), not lysine biosynthesis.
    action: MODIFY
    reason: >-
      Mammals do not synthesize lysine via saccharopine; AASS is catabolic. The correct
      catalytic activities are the NADP+, L-lysine-forming reductase (GO:0047130) and the
      NAD+, L-glutamate-forming dehydrogenase (GO:0047131). The lysine-forming SDH direction
      (GO:0004754) is the wrong physiological direction for the human enzyme.
    proposed_replacement_terms:
    - id: GO:0047131
      label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
    supported_by:
    - reference_id: file:human/AASS/AASS-uniprot.txt
      supporting_text: >-
        the lysine ketoglutarate reductase and saccharopine dehydrogenase
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: located_in
  review:
    summary: >-
      ISS transfer of cytosolic localization from the Drosophila ortholog (UniProtKB:Q9VLX0),
      likely associated with the reported fly moonlighting role. Contradicts the
      mitochondrial-matrix localization of human AASS.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Human AASS has an N-terminal mitochondrial transit peptide and is experimentally
      localized to the mitochondrial matrix; a cytosolic localization transferred from a fly
      ortholog is not supported and conflicts with the core compartment. Marked over-annotated.
    propagation_review:
      root_cause: PROPAGATION_BAD
      failure_modes:
      - COMPARTMENT_OR_COMPLEX_MISMATCH
      source_entities:
      - source_id: UniProtKB:Q9VLX0
        source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Human AASS has a mitochondrial transit peptide and matrix localization; cytosolic
          transfer is unsafe.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: located_in
  review:
    summary: >-
      ISS transfer of nuclear localization from the Drosophila ortholog (UniProtKB:Q9VLX0),
      linked to the fly transcriptional moonlighting role. No human evidence; conflicts with
      the established mitochondrial-matrix localization.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Nuclear localization is part of the Drosophila-specific moonlighting function and is
      not validated for the human mitochondrial-matrix enzyme. Marked over-annotated.
    propagation_review:
      root_cause: PROPAGATION_BAD
      failure_modes:
      - COMPARTMENT_OR_COMPLEX_MISMATCH
      source_entities:
      - source_id: UniProtKB:Q9VLX0
        source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Nuclear localization is part of the fly moonlighting role; not validated for the
          human mitochondrial-matrix enzyme.
- term:
    id: GO:0042393
    label: histone binding
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: enables
  review:
    summary: >-
      ISS transfer of histone binding from the Drosophila ortholog (UniProtKB:Q9VLX0),
      associated with the reported fly chromatin/transcription moonlighting role. Not
      supported for human AASS.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Histone binding was inferred from the fly moonlighting function and transferred by
      similarity; there is no human experimental support, and it is inconsistent with the
      mitochondrial-matrix metabolic role. Marked over-annotated.
    propagation_review:
      root_cause: PROPAGATION_BAD
      failure_modes:
      - FUNCTIONAL_DIVERGENCE
      source_entities:
      - source_id: UniProtKB:Q9VLX0
        source_label: Drosophila melanogaster LKR/SDH (dLKR/SDH)
        source_status: SUPPORTS_SOURCE_BUT_NOT_TARGET
        comment: >-
          Histone binding tied to the fly chromatin moonlighting role; not validated for
          human AASS.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: TAS
  original_reference_id: PMID:10567240
  qualifier: located_in
  review:
    summary: >-
      Author statement (TAS) that the bifunctional LKR/SDH enzyme is a mitochondrial protein,
      based on sequence analysis of the mammalian (mouse) enzyme. Consistent with the human
      mitochondrial localization.
    action: ACCEPT
    reason: >-
      Corroborates mitochondrial localization; the paper characterizes the mammalian
      bifunctional LKR/SDH and infers a mitochondrial targeting sequence.
    supported_by:
    - reference_id: PMID:10567240
      supporting_text: >-
        the bifunctional enzyme is likely to be a mitochondrial protein.
core_functions:
- description: >-
    Lysine-ketoglutarate reductase (LKR) activity: the N-terminal domain condenses
    L-lysine with 2-oxoglutarate to form L-saccharopine, using NADPH, as the first
    committed step of the saccharopine pathway of L-lysine degradation in the
    mitochondrial matrix.
  molecular_function:
    id: GO:0047130
    label: saccharopine dehydrogenase (NADP+, L-lysine-forming) activity
  directly_involved_in:
  - id: GO:0019477
    label: L-lysine catabolic process
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:463877
    supporting_text: >-
      In all instances there was a deficiency in lysine-ketoglutarate reductase,
      saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
  - reference_id: PMID:10775527
    supporting_text: >-
      The first two steps in the mammalian lysine-degradation pathway are catalyzed by
      lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
      resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
- description: >-
    Saccharopine dehydrogenase (SDH) activity: the C-terminal domain oxidizes
    L-saccharopine to L-2-aminoadipate-6-semialdehyde (alpha-aminoadipic semialdehyde)
    and L-glutamate, reducing NAD+, as the second step of the saccharopine pathway of
    L-lysine degradation in the mitochondrial matrix.
  molecular_function:
    id: GO:0047131
    label: saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity
  directly_involved_in:
  - id: GO:0019477
    label: L-lysine catabolic process
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:463877
    supporting_text: >-
      In all instances there was a deficiency in lysine-ketoglutarate reductase,
      saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
  - reference_id: PMID:10775527
    supporting_text: >-
      The first two steps in the mammalian lysine-degradation pathway are catalyzed by
      lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively,
      resulting in the conversion of lysine to alpha-aminoadipic semialdehyde.
references:
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      ISS pipeline reference. The transferred nuclear/transcriptional and lysine-forming
      annotations derive from the Drosophila ortholog (UniProtKB:Q9VLX0) and are not
      supported for human AASS.
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PAN-GO/IBA pipeline; correctly recovers the core saccharopine-pathway function and
      lysine catabolic process.
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: SubCell keyword mapping to mitochondrion; consistent with experimental data.
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Ensembl Compara transfer from mouse Q99K67; correctly places AASS in the mitochondrial matrix.
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      ARBA/RHEA/EC mapping recovering both catalytic activities (EC 1.5.1.8 and 1.5.1.9);
      consistent with UniProt and experimental annotations.
- id: PMID:10567240
  title: 'Lysine degradation through the saccharopine pathway in mammals: involvement
    of both bifunctional and monofunctional lysine-degrading enzymes in mouse.'
  findings:
  - statement: >-
      Characterizes a mammalian (mouse) bifunctional lysine-oxoglutarate
      reductase/saccharopine dehydrogenase and infers mitochondrial localization; also
      reports starvation induction.
    reference_section_type: ABSTRACT
    supporting_text: >-
      the bifunctional enzyme is likely to be a mitochondrial protein.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Establishes the mammalian bifunctional LKR/SDH and its mitochondrial
      localization and starvation induction (ortholog of human AASS).
- id: PMID:10775527
  title: Identification of the alpha-aminoadipic semialdehyde synthase gene, which
    is defective in familial hyperlysinemia.
  findings:
  - statement: >-
      Identifies human AASS as a bifunctional enzyme (N-terminal LKR ~ yeast LYS1,
      C-terminal SDH ~ yeast LYS9) catalyzing the first two steps of lysine degradation;
      inactivating mutations cause hyperlysinemia.
    reference_section_type: ABSTRACT
    supporting_text: >-
      we propose that AASS catalyzes the first two steps of the major lysine-degradation
      pathway in human cells and that inactivating mutations in the AASS gene are a cause
      of hyperlysinemia.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Defining reference for the human gene, its bifunctional domain
      organization, and the disease link (HYPLYS1).
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings:
  - statement: AASS is a member of the high-confidence human mitochondrial proteome (MitoCoP).
    reference_section_type: ABSTRACT
    supporting_text: >-
      mitochondrial high-confidence proteome of >1,100 proteins (MitoCoP)
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified proteomics dataset; supports mitochondrial localization at proteome
      scale (HTP evidence).
- id: PMID:463877
  title: 'Familial hyperlysinemia: enzyme studies, diagnostic methods, comments on
    terminology.'
  findings:
  - statement: >-
      Enzyme studies in hyperlysinemia patients show combined deficiency of
      lysine-ketoglutarate reductase and saccharopine dehydrogenase; the activities
      co-purify from human liver and localize to the same protein.
    reference_section_type: ABSTRACT
    supporting_text: >-
      In all instances there was a deficiency in lysine-ketoglutarate reductase,
      saccharopine dehydrogenase, and saccharopine oxidoreductase activities.
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Experimental basis for both AASS enzyme activities and for the
      type I / saccharopinuria distinction.
- id: Reactome:R-HSA-70938
  title: lysine + alpha-ketoglutarate +NADPH + H+ => saccharopine + NADP+ + H2O
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Reactome reaction for the LKR step; localized to the mitochondrial matrix.
- id: Reactome:R-HSA-70940
  title: saccharopine + NAD+ + H2O => alpha-aminoadipic semialdehyde + glutamate +
    NADH + H+
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Reactome reaction for the SDH step; localized to the mitochondrial matrix.
proposed_new_terms: []
suggested_questions:
- question: >-
    Does human AASS have any validated moonlighting function outside the mitochondrion (e.g.
    a nuclear/transcriptional role analogous to that reported for the Drosophila ortholog),
    or is such a role restricted to insects?
suggested_experiments:
- description: >-
    Test whether endogenous AASS is detectable in the nucleus of human cells and whether it
    associates with chromatin or represses transcription, to determine if the Drosophila-derived
    transcriptional moonlighting annotations are conserved in humans.